IHU reConnect - first center of excellence for hearing disorders

Governance and organization

The reConnect Institute is a foundation hosted by the Institut Pasteur and formed by its five founding members: AP-HP, Inserm, the Université Paris-Cité, the Fondation Pour l’Audition and the Institut Pasteur.

The reConnect Institute’s directory board relies on several bodies and committees to ensure its smooth running and to develop its scientific and medical strategy.

Our bodies

Management committee

The main mission of the reConnect Institute’s management committee is to ensure the smooth running of the Institute. It validates strategic and financial orientations.

Chaired by Benoît Dubuis, its members meet 3 times a year.

Composition of the management committee:

President: Benoît Dubuis
Representatives of the founding members: Yasmine Belkaïd (director of the Institut Pasteur), Jean-Pierre Meyers (president of the Fondation Pour l’Audition), Nicolas Revel (director of the AP-HP), Didier Samuel (CEO of the Institut national de la santé and the Inserm), Edouard Kaminski (president of the Université Paris Cité)
A qualified person: Jean-Antoine Girault, research director, Inserm
A representative of the hosting foundation (Institut Pasteur): Françoise Perriolat, financial director of the Institut Pasteur
A government commissioner representative: Nacer Boubenna, scientific director, head of the Département Biologie/Santé A4 SSRI, Direction Générale de la Recherche et de l’Innovation, ministère de l’Enseignement Supérieur et de la Recherche
Partners’ representatives:
- Patients’ associations: Yann Griset, president of SurdiFrance
- ORL College: Michel Mondain, president of the Collège Français d’Oto-Rhino-Laryngologie & Chirurgie Cervico-Faciale
The reConnect Institut directory board:
- Anne-Lise Giraud, director
- Anne-Dominique Lodeho-Devauchelle, deputy director
- Yann Nguyen, clinical director
- Claire Paquet, scientific director

International scientific council

The International scientific council is formed by international specialists and researchers in the fields of hearing, speech and cognitive disorders. Its role is to advise the scientific and medical orientations of reConnect.

Directory board

Its main mission is to monitor the activities of the Institute and to implement the scientific and medical orientations.

It is formed by:

Anne-Lise Giraud, director
Anne-Dominique Lodeho-Devauchelle, deputy director
Yann Nguyen, clinical director
Claire Paquet, scientific director

Steering committee

The steering committee is formed by the workpackages leaders and is chaired by the director of the reConnect Institute, Anne-Lise Giraud. Its mission is to provide some advice on scientific and medical strategies.

Innovation committee

The Innovation Committee is responsible for defining the strategy and implementing the technology transfer of the reConnect Institute's discoveries, transforming them into products and solutions designed to improve the lives of people with speech, hearing and/or dementia disorders. It also coordinates the management and distribution of intellectual property within the institute. The committee is led by the Institute's Director, Anne-Lise Giraud, and Innovation Director, Nicolas Le Goff. It brings together innovation representatives from the five founding members of reConnect.

Our bodies

Management committee

The main mission of the reConnect Institute’s management committee is to ensure the smooth running of the Institute. It validates strategic and financial orientations.

Chaired by Benoît Dubuis, its 13 members meets 3 times a year.

Composition of the management committee:

President: Benoît Dubuis
Representatives of the founding members: Yasmine Belkaïd (director of the Institut Pasteur), Jean-Pierre Meyers (president of the Fondation Pour l’Audition), Nicolas Revel (director of the AP-HP), Didier Samuel (CEO of the Institut national de la santé and the Inserm), Edouard Kaminski (president of the Université Paris Cité)
A qualified person: Jean-Antoine Girault, research director, Inserm
A representative of the hosting foundation (Institut Pasteur): Françoise Perriolat, financial director of the Institut Pasteur
A government commissioner representative: Nacer Boubenna, scientific director, head of the Département Biologie/Santé A4 SSRI, Direction Générale de la Recherche et de l’Innovation, ministère de l’Enseignement Supérieur et de la Recherche
Partners’ representatives:
- Patients’ associations: Yann Griset, president of SurdiFrance
- ORL College: Michel Mondain, president of the Collège Français d’Oto-Rhino-Laryngologie & Chirurgie Cervico-Faciale
The reConnect Institut directory board:
- Anne-Lise Giraud, director
- Anne-Dominique Lodeho-Devauchelle, deputy director
- Yann Nguyen, clinical director
- Claire Paquet, scientific director

International scientific council

Directory board

Its main mission is to monitor the activities of the Institute and to implement the scientific and medical orientations.

It is formed by:

Anne-Lise Giraud, director
Anne-Dominique Lodeho-Devauchelle, deputy director
Yann Nguyen, clinical director
Claire Paquet, scientific director

Steering committee

Innovation committee

Our founders and partners

The Institut Pasteur, a non-profit foundation with recognized charitable status set up by Louis Pasteur in 1887, is today an internationally renowned center for biomedical research. In the pursuit of its mission to tackle diseases in France and throughout the world, the Institut Pasteur operates in four main areas: research, public health, training, and development of research applications. The Institut Pasteur is a globally recognized leader in infectious diseases, microbiology, and immunology, with research focusing on the biology of living systems. Among its areas of investigation are emerging infectious diseases, antimicrobial resistance, certain cancers, neurodegenerative diseases, and brain connectivity disorders. The Institut Pasteur's outstanding research is facilitated by the development of a technological environment of the highest standard, with core facilities for nanoimaging, computational biology and artificial intelligence. Since its inception, 10 Institut Pasteur scientists have been awarded the Nobel Prize for Medicine, including two in 2008 for the 1983 discovery of the human immunodeficiency virus (HIV) that causes AIDS.

The Institut Pasteur is part of the Pasteur Network a worldwide network of more than 30 members on five continents, united by Pasteurian values, that contribute to global health.

Since July 1, 2021, the Institut Pasteur is a research partner organization of Université Paris Cité.

The Institut Pasteur is part of the Pasteur Network a worldwide network of more than 30 members on five continents, united by Pasteurian values, that contribute to global health.

Since July 1, 2021, the Institut Pasteur is a research partner organization of Université Paris Cité.

Find out more

About Assistance Publique - Hôpitaux de Paris / Greater Paris University Hospitals: The leading hospital and university centre (CHU) in Europe, Greater Paris University Hospitals and its 38 hospitals are organised into six hospital-university groups (AP-HP. Centre - Université Paris Cité ; AP-HP. Sorbonne Université ; AP-HP. Nord - Université Paris Cité ; AP-HP. Université Paris Saclay ; AP-HP. Hôpitaux Universitaires Henri Mondor et AP-HP. Hôpitaux Universitaires Paris Seine-Saint-Denis) and are centered around five universities in the Île-de-France region. Closely linked to large research bodies, Greater Paris University Hospitals include eight international hospital-university institutes (Institut du Cerveau, ICAN, IMAGINE, FOReSIGHT, PROMETHEUS, InovAND, reConnect, THEMA) and the largest French health data repository (EDS). As a major stakeholder in applied research and health innovation, Greater Paris University Hospitals hold a portfolio of 750 active patents, and each year its clinicians sign off nearly 11000 scientific publications and over 4,000 research projects are under development, all promoters combined. In 2020, Greater Paris University Hospitals were awarded the Institut Carnot label, which is recognition of the quality of partner research: Carnot@AP-HP offers industrial stakeholders applied and clinical research solutions in the health sector. In 2015, Greater Paris University Hospitals also founded the Greater Paris University Hospitals Research Foundation to support the biomedical and health research performed in all its hospitals.

Find out more

Université Paris Cité is a multi-disciplinary, research-intensive internationally renowned university delivering high-quality education and world-leading research, with the “Initiative d'Excellence" label. Université Paris Cité is recognised for its programme diversity, its capacity for innovation as well as for its active participation in the development of the European Education and Research areas.
Université Paris Cité comprises three faculties (Health, Sciences and Humanities and Social Sciences), a component institution, the Institut de Physique du Globe de Paris, and a partner research organisation, the Institut Pasteur.
Université Paris Cité has 63,000 students, 7,500 professors and researchers, 21 doctoral schools and 117 research laboratories.

Find out more

Founded in 1964, Inserm is a public scientific and technological institute which operates under the joint authority of the French Ministries of Health and Research. The institute is dedicated to biomedical research and human health, and is involved in the entire range of activities from the laboratory to the patient’s bedside. It also partners with the most prestigious research institutions in the world that are committed to scientific challenges and progress in these fields.

Inserm brings together 15,000 researchers, engineers, technicians and administrative staff, all with one shared objective: improve health by advancing knowledge about living organisms and diseases, developing innovative treatment modalities and conducting research on public health.

Find out more

Fondation Pour l'Audition, chaired by Mr. Jean-Pierre Meyers, has been recognized as a public utility since 2015 and works daily to advance the cause of auditory health. This legacy imbues the brand with a culture of concrete and positive on-the-ground action.

The foundation's mission is threefold: to support research and innovation, improve the daily lives of deaf and hard of hearing individuals and their loved ones, and also mobilize public opinion through prevention and awareness to protect everyone's auditory capital.

By creating and rallying projects in the field of research with the establishment of the Institute de l'Audition, a center of the Institut Pasteur, the foundation aims to mobilize all talents who share the ambition of helping deaf or hard of hearing individuals lead better daily lives. To act in service of the development of research in the field of hearing, the foundation thus engages in an ambitious program that will structure and accelerate research, care, and prevention in the field of hearing in France.

Find out more